Thu, May 19, 2022
Wed, May 18, 2022
Tue, May 17, 2022
Mon, May 16, 2022
Sun, May 15, 2022
Fri, May 13, 2022

Matthew Harrison Maintained (BLUE) at Sell with Decreased Target to $3 on, May 17th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-3-on-may-17th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Sell with Decreased Target from $5 to $3 on, May 17th, 2022.

Matthew has made no other calls on BLUE in the last 4 months.



There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $8 on, Wednesday, April 6th, 2022
  • Yaron Werber of "Cowen & Co." Downgraded from Buy to Hold on, Wednesday, April 6th, 2022
  • Yanan Zhu of "Wells Fargo" Maintained at Hold with Decreased Target to $8 on, Tuesday, March 8th, 2022


This is the rating of the analyst that currently disagrees with Matthew


  • Gena Wang of "Barclays" Maintained at Sell with Decreased Target to $3 on, Tuesday, May 10th, 2022

Publication Contributing Sources